Literature DB >> 27890486

Towards a multidisciplinary approach to understand and manage obesity and related diseases.

Stephan C Bischoff1, Yves Boirie2, Tommy Cederholm3, Michael Chourdakis4, Cristina Cuerda5, Nathalie M Delzenne6, Nicolaas E Deutz7, Denis Fouque8, Laurence Genton9, Carmen Gil10, Berthold Koletzko11, Miguel Leon-Sanz12, Raanan Shamir13, Joelle Singer14, Pierre Singer15, Nanette Stroebele-Benschop16, Anders Thorell17, Arved Weimann18, Rocco Barazzoni19.   

Abstract

Overnutrition and sedentary lifestyle result in overweight or obesity defined as abnormal or excessive fat accumulation that may impair health. According to the WHO, the worldwide prevalence of obesity nearly doubled between 1980 and 2008. In 2008, over 50% of both men and women in the WHO European Region were overweight, and approximately 23% of women and 20% of men were obese. Comprehensive diagnostic and therapeutic approaches should include nutritional treatment to favor the best metabolic and nutritional outcome, as well as to induce potential disease-specific benefits from selected nutritional regimens. Obesity is usually accompanied by an increased muscle mass. This might explain why obesity, under particular circumstances such as cancer or high age, might have protective effects, a phenomenon named the 'obesity paradox'. However, loss of muscle mass or function can also occur, which is associated with poor prognosis and termed 'sarcopenic obesity'. Therefore, treatment recommendations may need to be individualized and adapted to co-morbidities. Since obesity is a chronic systemic disease it requires a multidisciplinary approach, both at the level of prevention and therapy including weight loss and maintenance. In the present personal review and position paper, authors from different disciplines including endocrinology, gastroenterology, nephrology, pediatrics, surgery, geriatrics, intensive care medicine, psychology and psychiatry, sports medicine and rheumatology, both at the basic science and clinical level, present their view on the topic and underline the necessity to provide a multidisciplinary approach, to address this epidemic.
Copyright © 2016 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Fatty liver disease; Metabolic syndrome; Microbiota; Multidisciplinary; Sarcopenic obesity; Weight maintenance

Mesh:

Year:  2016        PMID: 27890486     DOI: 10.1016/j.clnu.2016.11.007

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  44 in total

1.  Depression Severity as a Risk Factor of Sarcopenic Obesity in Morbidly Obese Patients.

Authors:  V Venant; M Pouget; C Lahaye; E Gentes; B Pereira; C Lambert; J Debarges; C Domingues-Faria; C Palmier-Forestier; N Farigon; M Miolanne; Y Boirie
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

2.  Four main barriers to weight loss maintenance? A quantitative analysis of difficulties experienced by obese patients after successful weight reduction.

Authors:  Martin Fischer; Nadine Oberänder; Arved Weimann
Journal:  Eur J Clin Nutr       Date:  2020-01-30       Impact factor: 4.016

3.  Feasibility and acceptability of a mobile messaging program within a church-based healthy living intervention for African Americans and Latinos.

Authors:  Margaret D Whitley; Denise D Payán; Karen R Flórez; Malcolm V Williams; Eunice C Wong; Cheryl A Branch; Kathryn P Derose
Journal:  Health Informatics J       Date:  2019-06-15       Impact factor: 2.681

4.  Eat, Pray, Move: A Pilot Cluster Randomized Controlled Trial of a Multilevel Church-Based Intervention to Address Obesity Among African Americans and Latinos.

Authors:  Kathryn P Derose; Malcolm V Williams; Karen R Flórez; Beth Ann Griffin; Denise D Payán; Rachana Seelam; Cheryl A Branch; Jennifer Hawes-Dawson; Michael A Mata; Margaret D Whitley; Eunice C Wong
Journal:  Am J Health Promot       Date:  2018-11-25

Review 5.  [The intestinal microbiome and metabolic diseases : From obesity to diabetes and nonalcoholic steatohepatitis].

Authors:  S C Bischoff
Journal:  Internist (Berl)       Date:  2017-05       Impact factor: 0.743

Review 6.  Ghrelin forms in the modulation of energy balance and metabolism.

Authors:  Gianluca Gortan Cappellari; Rocco Barazzoni
Journal:  Eat Weight Disord       Date:  2018-10-24       Impact factor: 4.652

Review 7.  Sarcopenic Obesity: Time to Meet the Challenge.

Authors:  Rocco Barazzoni; Stephan Bischoff; Yves Boirie; Luca Busetto; Tommy Cederholm; Dror Dicker; Hermann Toplak; Andre Van Gossum; Volkan Yumuk; Roberto Vettor
Journal:  Obes Facts       Date:  2018-07-18       Impact factor: 3.942

8.  Cachexia-associated adipose loss induced by tumor-secreted leukemia inhibitory factor is counterbalanced by decreased leptin.

Authors:  Gurpreet K Arora; Arun Gupta; Sriram Narayanan; Tong Guo; Puneeth Iyengar; Rodney E Infante
Journal:  JCI Insight       Date:  2018-07-26

Review 9.  Obesity genetics and cardiometabolic health: Potential for risk prediction.

Authors:  Dharambir K Sanghera; Cynthia Bejar; Sonali Sharma; Rajeev Gupta; Piers R Blackett
Journal:  Diabetes Obes Metab       Date:  2019-03-20       Impact factor: 6.577

Review 10.  Sarcopenic Obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives.

Authors:  Chrysi Koliaki; Stavros Liatis; Maria Dalamaga; Alexander Kokkinos
Journal:  Curr Obes Rep       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.